The first study included a combined group that received ordinary medical treatment for nausea.

The first study included a combined group that received ordinary medical treatment for nausea, but not acupuncture. In that combined group only one one fourth of the nauseous individuals experienced any relief. Related StoriesFDA grants accelerated approval for Tagrisso to treat patients with advanced NSCLCStudy displays uncommon HER2 missense mutations do not spread breasts cancer on their ownNew RNA check of blood platelets can be used to identify location of cancerThe acupuncture research of 215 individuals who were undergoing radiation treatment in the belly or pelvic area chose by lot among both of these acupuncture types.The agreement grants Abbott a license to BG Medicine’s intellectual house related to galectin-3. Financial conditions weren’t disclosed. Heart failure is one of the most costly medical ailments in the world, with 37 % of U.S. Medicare dollars alone spent on heart conditions each full year, said Michael Warmuth, senior vice president, diagnostics items, Abbott. Novel markers like galectin-3 possess the potential to create essential contributions to improving individual and financial outcomes as we work to better understand this deadly and expensive disease. Related StoriesLiposomal sizing and the Coulter basic principle: an interview with Professor Melvin E. KlegermanFidgeting while seated may be best for usGood sleep patterns are best for your heartGalectin-3 is usually a protein that plays an integral part in the biological features related to the initiation and progression of cardiac fibrosis and scarring which really is a leading cause of heart failure .